诱导多能干细胞
胚胎干细胞
体细胞
药物发现
干细胞
生物
细胞疗法
细胞
计算生物学
细胞生物学
计算机科学
生物信息学
遗传学
基因
作者
Yuji Mochiduki,Keisuke Okita
标识
DOI:10.1002/biot.201100356
摘要
The induction of pluripotency can be achieved by forced expression of defined factors in somatic cells. The established cells, termed induced pluripotent stem (iPS) cells, have pluripotency and an infinite capacity for self-renewal in common with embryonic stem (ES) cells. Patient-specific iPS cells could be a useful source for drug discovery and cell transplantation therapies; however, the original method for iPS cell generation had several issues that were obstacles to their clinical application. Recent studies have brought about various improvements for iPS cell generation and uncovered several characteristics of iPS cells. Here we summarize the current status of iPS cell studies, with a focus on the improved methods that can be used to generate iPS cells, and also refer to the future challenges.
科研通智能强力驱动
Strongly Powered by AbleSci AI